AZR

Azora Therapeutics, Inc. - Common Stock (AZR)

About Azora Therapeutics, Inc. - Common Stock (AZR)

Azora Therapeutics, Inc. is a biopharmaceutical company that develops therapies for immune-mediated inflammatory diseases. Its investigational oral drug, AT177, is being develop for inflammatory bowel diseases, with an initial focus on ulcerative colitis. The company was founded by Julie Saiki and Matthew Davidson which is headquartered in Los Angeles, CA.

Details

Daily high

$4.30

Daily low

$3.94

Price at open

$3.95

52 Week High

$8.75

52 Week Low

$1.31

Market cap

10.9M

Dividend yield

Volume

5,867

Avg. volume

47,789

P/E ratio

-.25

Azora Therapeutics, Inc. - Common Stock News